Natalizumab Therapy for Multiple Sclerosis

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy

(2012) Tarek A. Yousry et al.   ANNALS OF NEUROLOGY

Value of MRI as a surrogate marker for PML in natalizumab long-term therapy

(2012) I. Ayzenberg et al.   JOURNAL OF NEUROLOGY

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial

(2012) David H Miller et al.   LANCET NEUROLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1

(2011) Carmen Bozic et al.   ANNALS OF NEUROLOGY

The clinical features of PML

(2011) J. R. BERGER   CLEVELAND CLINIC JOURNAL OF MEDICINE

Natalizumab and HSV meningitis

(2011) Erica Seiguer Shenoy et al.   JOURNAL OF NEUROVIROLOGY

Herpes encephalitis during natalizumab treatment in multiple sclerosis

(2011) A Kwiatkowski et al.   Multiple Sclerosis Journal

Immune reconstitution inflammatory syndrome in natalizumab-associated PML

(2011) I. L. Tan et al.   NEUROLOGY

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

(2011) P. W. O'Connor et al.   NEUROLOGY

Anti-JC virus antibodies: Implications for PML Risk Stratification

(2010) Leonid Gorelik et al.   ANNALS OF NEUROLOGY

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

(2010) Ernst-Wilhelm Radue et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Natalizumab para la esclerosis múltiple remitente-recurrente

(2010) A. Horga et al.   NEUROLOGIA

SEVERE CUTANEOUS CANDIDA INFECTION DURING NATALIZUMAB THERAPY IN MULTIPLE SCLEROSIS

(2010) S. Gutwinski et al.   NEUROLOGY

Primary central nervous system lymphoma in a patient treated with natalizumab

(2009) Andreas Schweikert et al.   ANNALS OF NEUROLOGY

Progressive multifocal leukoencephalopathy in HIV-1 infection

(2009) Paola Cinque et al.   LANCET INFECTIOUS DISEASES

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

(2009) Eva Havrdova et al.   LANCET NEUROLOGY

GLANCE: Results of a phase 2, randomized, double-blind, placebo-controlled study

(2009) A. D. Goodman et al.   NEUROLOGY

OCULAR TOXOPLASMOSIS DURING NATALIZUMAB TREATMENT

(2009) C. Zecca et al.   NEUROLOGY

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

(2009) B. O. Khatri et al.   NEUROLOGY

Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML)

(2009) Shamil R. Sunyaev et al.   PLoS Genetics

Seroepidemiology of Human Polyomaviruses

(2009) Jaime M. Kean et al.   PLoS Pathogens